Pregnancy and Childbirth in Women with Thalassemia Yesterday and Today

Pregnancy and Childbirth in Women with Thalassemia Yesterday and Today: a Multicentre Observational Study

Recent advances in the management of thalassemia have significantly improved life expectancy and quality of life of patients with this hemoglobinopathy, with a consequent increase in their reproductive potential and desire to have children.Since an initial report of a successful pregnancy in a woman with thalassemia major by Walker in 1969, hundreds of pregnancies have been reported so far, highlighting that women carefully managed in the preconception phase usually carry out a successful gestation and labor, both in case of spontaneous conception and assisted reproductive techniques.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

75

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cagliari, Italy, 09123
        • UniversityCagliari, OspPed Microcitemico, Cagliari

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

FEMALE THALASSEMIE DEPEND TRANSFUSION

Description

Inclusion Criteria:

  • Transfusion dependent and nontransfusion- dependent thalassemia
  • Pregnancy ended with the birth of a live or dead foetus
  • Pregnancy ended in miscarriage or voluntary abortion
  • Pregnancy in progress

Exclusion Criteria:

  • Other types of anemia
  • Pregnancy not initiated despite assisted fertilization practices
  • Subjects unwilling to sign informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
number of pregnancies in women with beta thalassemia followed in Italian centres
Time Frame: 15 YEARS
To evaluate the number of pregnancies in women with beta thalassemia followed in Italian centres and how the increase in the average age of the thalassemia population impact on the number of new pregnancies over time
15 YEARS
number of pregnancies spontaneously
Time Frame: 15 YEARS
many pregnancies occurred spontaneously
15 YEARS
number of pregnancies after hormonal stimulation
Time Frame: 15 YEARS
number of pregnancies after hormonal stimulation
15 YEARS
likelihood of miscarriage
Time Frame: 15 YEARS
To evaluate the likelihood of miscarriage
15 YEARS
foetal death
Time Frame: 15 YEARS
To evaluate foetal death
15 YEARS

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 9, 2023

Primary Completion (Actual)

May 14, 2024

Study Completion (Actual)

May 14, 2024

Study Registration Dates

First Submitted

March 17, 2025

First Submitted That Met QC Criteria

March 17, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 17, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Thalassemia

Subscribe